Boosting muscle lymphatics to help Duchenne muscular dystrophy
Official title: Role of Skeletal Muscle Lymphatics in Duchenne Muscular Dystrophy Regulation
Funded at Texas A&m University Health Science Ctr · NIH-11308326 · Data updated 2026-11-12
Researchers are trying to grow more lymphatic vessels in muscle to lower inflammation and help people with Duchenne muscular dystrophy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | May 24, 2022 |
| Project end | April 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $459,760 |
| NIH project number | 5R01AR080129-05 |
| Project ID | NIH-11308326 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with Duchenne muscular dystrophy, particularly those with evidence of ongoing muscle inflammation, would be the most relevant candidates for related future clinical trials.
✕Less likely to help
People without Duchenne muscular dystrophy or those with very advanced, irreversible muscle or organ damage may not benefit from this lymphatic-targeted approach.
What this research studies
This project uses lab models of Duchenne muscular dystrophy to study how the lymphatic system in muscle affects inflammation and weakness. Scientists increase a lymphatic growth protein called VEGF-D in muscle and measure whether that makes more lymphatic vessels and improves lymph flow. They look at muscle size, strength, and inflammatory markers in affected muscles to see if the changes help. Findings could guide new treatments that target muscle lymphatics to protect or repair muscle in DMD.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that reduce muscle inflammation and slow muscle loss in people with Duchenne muscular dystrophy.
How similar studies have gone: Early animal data show that boosting lymphatic growth can increase vessel density and sometimes improve muscle weight and strength, but translating this approach to people is still new and unproven.
Where this research is happening
-
Texas A&m University Health Science Ctr
College Station, United States Active
Researchers
- Principal investigator: Muthuchamy, Mariappan — Texas A&m University Health Science Ctr
- Study coordinator: Muthuchamy, Mariappan
Related research
Other NIH-funded projects on the same topics.
-
Advancing manufacturing and release testing for a Duchenne gene editing therapy
A project to optimize how a dual-vector AAV gene editing treatment for Duchenne muscular dystrophy is made and tested, so it can move toward clinical use.
-
Understanding why Duchenne Muscular Dystrophy worsens and how to stop it
A research team at USC is studying Duchenne muscular dystrophy to find out why the disease continues to progress and how to interrupt harmful changes in muscle tissue.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
MR clues to how nNOS affects energy use and blood flow in Becker and Duchenne muscular dystrophy
This project looks at how advanced MRI tests can track muscle energy and blood flow changes in people with Becker and Duchenne muscular dystrophy as new gene therapies are explored.
-
Digital motor-skill tracking for infants with Duchenne Muscular Dystrophy using wearables
A wearable-sensor project aims to quietly track and quantify how motor skills develop in babies and young boys with Duchenne Muscular Dystrophy.
-
Genetic factors that influence Duchenne Muscular Dystrophy progression
A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.